Conclusin Los anlogos de GLP-1 representan un avance teraputico clave en el manejo de la diabetes y la obesidad , con efectos que van ms all del control glucmico
Symptom onset ranged from 2 to 39 days after vaccination, with common clinical features including palpitations, weight loss, heat intolerance, tremors, fatigue, and anxietytypical manifestations of hyperthyroidism
As with any injection, there may be slight bruising, redness, and soreness at the injection site.
[...] To view or add a comment, sign in Eli Lilly's VERVE-102, an investigational single-dose gene-editing medicine, shows groundbreaking potential as a one-time treatment for hypercholesterolemia by durably reducing LDL cholesterol by up to 62% and PCSK9 by up to 88% in the Phase 1b Heart-2 trial